[
  {
    "ts": "2025-10-17T13:08:00+00:00",
    "headline": "WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure?",
    "summary": "West Pharma's Q3 numbers hinge on robust GLP-1 and biologics demand, but labor constraints, tariffs, and plant shutdowns could test its margin resilience.",
    "url": "https://finance.yahoo.com/news/wst-q3-earnings-preview-glp-130800485.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3bb9ce0d-cd24-370e-b353-cabcf9c3e148",
      "content": {
        "id": "3bb9ce0d-cd24-370e-b353-cabcf9c3e148",
        "contentType": "STORY",
        "title": "WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure?",
        "description": "",
        "summary": "West Pharma's Q3 numbers hinge on robust GLP-1 and biologics demand, but labor constraints, tariffs, and plant shutdowns could test its margin resilience.",
        "pubDate": "2025-10-17T13:08:00Z",
        "displayTime": "2025-10-17T13:08:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tj8ZNhTW.EaFq0gf4epBdA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m7FUnW0Rc7kH4rOUyfanWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/wst-q3-earnings-preview-glp-130800485.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wst-q3-earnings-preview-glp-130800485.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            },
            {
              "symbol": "GMED"
            },
            {
              "symbol": "MCK"
            },
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T12:26:00+00:00",
    "headline": "Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings",
    "summary": "Strong TAVR demand and expanding valve therapies are set to power EW's Q3 results despite lower EPS estimates.",
    "url": "https://finance.yahoo.com/news/robust-tavr-growth-drive-edwards-122600493.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ddbe0e33-ab76-37d4-8570-3e0e0ab0465d",
      "content": {
        "id": "ddbe0e33-ab76-37d4-8570-3e0e0ab0465d",
        "contentType": "STORY",
        "title": "Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings",
        "description": "",
        "summary": "Strong TAVR demand and expanding valve therapies are set to power EW's Q3 results despite lower EPS estimates.",
        "pubDate": "2025-10-17T12:26:00Z",
        "displayTime": "2025-10-17T12:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/d75c1f3a4ca0523531a6e5515376f55b",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ql.gnzdrLc0CQE9djdB50A--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d75c1f3a4ca0523531a6e5515376f55b.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sZ5dFDl2iSnAW.zL7TxiYw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d75c1f3a4ca0523531a6e5515376f55b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/robust-tavr-growth-drive-edwards-122600493.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/robust-tavr-growth-drive-edwards-122600493.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]